So sorry to hear about the loss of your mother. The delay for L - likely due to the unanticipated pseudoprogression issue - has been more than frustrating, it’s been devastating... for shareholders, but more importantly, for so many solid tumor cancer patients. The second Direct trial has had to be put off so many times due to all funds having to be allocated towards getting L to the finish line.
Sorry to learn about your mother. Like you, I am hoping for many patients to be able to gain access to this needed treatment platform. My heartfelt condolences and best wishes.
News 
Market Data 
Discover 
